These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8862425)

  • 1. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
    Schwartz MD; Geraghty RJ; Panganiban AT
    Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
    Lee YH; Schwartz MD; Panganiban AT
    Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
    Raja NU; Jabbar MA
    Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
    Deora A; Spearman P; Ratner L
    Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein.
    Handley MA; Paddock S; Dall A; Panganiban AT
    Virology; 2001 Dec; 291(2):198-207. PubMed ID: 11878889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
    Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
    Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tethered virions are intermediates in the assembly and release of HIV-1 particles.
    Karetnikov A; Suomalainen M
    Virology; 2010 Nov; 407(2):289-95. PubMed ID: 20850859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
    Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
    PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
    González ME; Carrasco L
    Virology; 2001 Jan; 279(1):201-9. PubMed ID: 11145902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
    McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
    Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.
    Stephens EB; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Nothnick W; Wong SW; Gunderson R; Berman NE; Singh DK
    Virology; 2002 Feb; 293(2):252-61. PubMed ID: 11886245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
    Bolduan S; Votteler J; Lodermeyer V; Greiner T; Koppensteiner H; Schindler M; Thiel G; Schubert U
    Virology; 2011 Jul; 416(1-2):75-85. PubMed ID: 21601230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
    Van Damme N; Guatelli J
    Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
    Friborg J; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):10-22. PubMed ID: 8548340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release.
    Varthakavi V; Smith RM; Martin KL; Derdowski A; Lapierre LA; Goldenring JR; Spearman P
    Traffic; 2006 Mar; 7(3):298-307. PubMed ID: 16497224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.